228 related articles for article (PubMed ID: 14556648)
1. N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.
Paclet MH; Davis C; Kotsonis P; Godovac-Zimmermann J; Segal AW; Dekker LV
Biochem J; 2004 Jan; 377(Pt 2):469-77. PubMed ID: 14556648
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils.
Selvatici R; Falzarano S; Mollica A; Spisani S
Eur J Pharmacol; 2006 Mar; 534(1-3):1-11. PubMed ID: 16516193
[TBL] [Abstract][Full Text] [Related]
3. Modulation of luminol chemiluminescence of fMet-Leu-Phe-stimulated neutrophils by affecting dephosphorylation and the metabolism of phosphatidic acid.
Arnhold J; Benard S; Kilian U; Reichl S; Schiller J; Arnold K
Luminescence; 1999; 14(3):129-37. PubMed ID: 10423573
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation in activated human neutrophils. Comparison of the effects of different classes of agonists and identification of the signaling pathways involved.
Rollet E; Caon AC; Roberge CJ; Liao NW; Malawista SE; McColl SR; Naccache PH
J Immunol; 1994 Jul; 153(1):353-63. PubMed ID: 7515926
[TBL] [Abstract][Full Text] [Related]
5. Staurosporine restores signaling and inhibits interleukin-8-induced chemotactic desensitization.
Johnston JA; Ferris DK; Wang JM; Longo DL; Oppenheim JJ; Kelvin DJ
Eur J Immunol; 1994 Oct; 24(10):2556-62. PubMed ID: 7925583
[TBL] [Abstract][Full Text] [Related]
6. (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Huang YJ; Chen IS; Tseng CP; Day YJ; Lin YC; Liao CH
Biochem Pharmacol; 2008 Feb; 75(3):688-97. PubMed ID: 17988652
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase gamma.
Burelout C; Thibault N; Levasseur S; Simard S; Naccache PH; Bourgoin SG
Mol Pharmacol; 2004 Aug; 66(2):293-301. PubMed ID: 15266020
[TBL] [Abstract][Full Text] [Related]
8. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils.
Tuluc F; Meshki J; Kunapuli SP
Int Immunopharmacol; 2003 Dec; 3(13-14):1775-90. PubMed ID: 14636828
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways involved in dephosphorylation and localization of the actin-binding protein cofilin in stimulated human neutrophils.
Djafarzadeh S; Niggli V
Exp Cell Res; 1997 Nov; 236(2):427-35. PubMed ID: 9367627
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phospholipase D activation by CYL-26z in formyl peptide-stimulated neutrophils involves the blockade of RhoA activation.
Kuan YH; Lin RH; Tsao LT; Chen YL; Tzeng CC; Wang JP
Biochem Pharmacol; 2005 Sep; 70(6):901-10. PubMed ID: 16024001
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst by cirsimaritin involves inhibition of phospholipase D signaling in rat neutrophils.
Wang JP; Chang LC; Hsu MF; Chen SC; Kuo SC
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):307-14. PubMed ID: 12237743
[TBL] [Abstract][Full Text] [Related]
12. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
Eckert RE; Jones SL
J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
[TBL] [Abstract][Full Text] [Related]
13. New chemotactic peptide analogs with high biological activity for human neutrophils.
Spisani S; Traniello S; Giuliani AL; Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Pochetti G; Lucente G
Biochem Int; 1992 May; 26(6):1125-35. PubMed ID: 1321622
[TBL] [Abstract][Full Text] [Related]
14. The PGE2-induced inhibition of the PLD activation pathway stimulated by fMLP in human neutrophils is mediated by PKA at the PI3-Kgamma level.
Burelout C; Thibault N; Harbour D; Naccache PH; Bourgoin SG
Biochem Pharmacol; 2007 Sep; 74(5):730-41. PubMed ID: 17631865
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastin.
Frederick MJ; Rodriguez LV; Johnston DA; Darnay BG; Grimm EA
Cancer Res; 1996 Jan; 56(1):138-44. PubMed ID: 8548753
[TBL] [Abstract][Full Text] [Related]
17. Anaesthetic sensitivity of fMLP-induced cell signalling in Xenopus oocytes.
Wittmann S; Fröhlich D; Mietens A; Daniels S
Int Immunopharmacol; 2006 Jan; 6(1):61-70. PubMed ID: 16332514
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
Cavicchioni G; Fraulini A; Falzarano S; Spisani S
Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
[TBL] [Abstract][Full Text] [Related]
19. FPRL-1 induces modifications of migration-associated proteins in human neutrophils.
Boldt K; Rist W; Weiss SM; Weith A; Lenter MC
Proteomics; 2006 Sep; 6(17):4790-9. PubMed ID: 16892486
[TBL] [Abstract][Full Text] [Related]
20. Substrate dependence of human neutrophil protein kinase C.
Gay JC; Stitt ES
Res Commun Chem Pathol Pharmacol; 1991 Apr; 72(1):13-25. PubMed ID: 2052746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
